The following resources may be helpful in considering participation in a clinical trial and learning more about new treatment options for HPV-associated cancers.
Cervivor is a global community of advocates who inspire and empower those affected by cervical cancer by educating and motivating them to use their voice.
The National Cervical Cancer Coalition (NCCC) is a grassroots nonprofit dedicated to serving women with, or at risk for, cervical cancer and HPV disease. In 2011, NCCC merged with American Sexual Health Association (ASHA), a nonprofit with a long history of educating and raising awareness on sexual health issues.
The Anal Cancer Foundation is dedicated to empowering anal cancer patients and accelerating prevention and treatment methods that eliminate this disease.
The Oral Cancer Foundation is a national nonprofit head and neck cancer organization, designed to reduce suffering and save lives through prevention, education, research funding, advocacy, and patient support activities.
The Head and Neck Cancer Alliance aims to advance prevention, detection, treatment and rehabilitation of oral, head and neck cancer through public awareness, research, advocacy and survivorship.
CancerCare® is the leading national organization dedicated to providing free, professional support services including counseling, support groups, educational workshops, publications and financial assistance to anyone affected by cancer. All CancerCare services are provided by oncology social workers and world-leading cancer experts.
As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC) is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community.
RTX‑321 Phase 1 Clinical Trial
Complete a patient screener to see if you may be able to participate.
Rubius Therapeutics is now enrolling patients in a phase 1 clinical trial of RTX-321 for the treatment of patients with HPV 16-associated cancers.
Based on the information provided, you may not meet the requirements for this study. We want to thank you for your interest – patient volunteers and their family members are an essential part of the development of new therapies for cancer. If you still would like to learn more about Red Cell Therapeutics™ and receive updates about clinical trials that might be available in your area for the potential treatment of cancer for yourself or a loved one, sign up here.
Thank you for your submission.
Someone from our Patient Advocacy Team may reach out to you to determine your interest and if you would meet the requirements to be evaluated by a study doctor for screening in the RTX-321 study. Your personal information, including information entered previously and discussed with our Patient Advocacy Team, may then be shared with a clinical study site.
Sign up to learn more about Red Cell Therapeutics™ and cancer clinical trials.
Please correct the following errors and submit the form again.